LOS ANGELES and AMSTERDAM – Renovaro Inc. (NASDAQ:RENB), known for its AI-driven early cancer diagnostics and therapeutics, has announced plans to acquire the remaining shares of Cyclomics, thereby ...
LOS ANGELES and AMSTERDAM, April 24, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (Nasdaq: RENB), a trailblazer in AI-driven early cancer diagnostics and therapeutics, and Cyclomics, a leader in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback